Bank of America’s Jaguar Health JAGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1
Closed -$28 6318
2025
Q4
$28 Buy
+1
New +$51 ﹤0.01% 7060
2025
Q3
Hold
0
8094
2025
Q2
Hold
0
8295
2025
Q1
Hold
0
8148
2024
Q4
Hold
0
7742
2024
Q3
Hold
0
7720
2024
Q2
Sell
-5
Closed -$33.1K 7631
2024
Q1
$21.6K Buy
+5
New +$21.9K ﹤0.01% 6739
2023
Q1
Hold
0
-$13 8038
2022
Q4
Hold
0
8045
2022
Q1
Hold
0
8506
2021
Q4
Hold
0
8418
2021
Q3
Hold
0
7826
2021
Q2
Hold
0
7898
2020
Q3
Hold
0
7024
2020
Q2
Hold
0
6962
2020
Q1
Hold
0
7038
2019
Q4
Hold
0
7234
2019
Q3
Hold
0
7361
2019
Q2
Hold
0
7292
2019
Q1
Hold
0
7258
2018
Q4
Hold
0
7233
2018
Q3
Hold
0
6724
2018
Q2
Hold
0
7201
2017
Q1
Hold
0
7103
2016
Q4
Hold
0
7173
2016
Q3
Hold
0
7228

Other funds holding JAGX

Bank of America's JAGX Position: Q1 2026 in Review

Bank of America sold out of Jaguar Health (JAGX) in Q1 2026, closing a stake of 1 share — an estimated $28 sold.

Bank of America first reported a position in JAGX in Q1 2024 and held it in 2 quarters. The position peaked at $21.6K in Q1 2024. 10 funds tracked by Wall St. Rank hold JAGX as of Q1 2026.

  • Bank of America reported no remaining Jaguar Health position as of Q1 2026 after selling out during the quarter.
  • Bank of America sold 1 Jaguar Health share in Q1 2026, an estimated $28.
  • Bank of America first reported a position in Jaguar Health in Q1 2024 and held it in 2 quarters.
  • Bank of America's Jaguar Health position peaked at $21.6K in Q1 2024.
  • 10 funds tracked by Wall St. Rank held Jaguar Health as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.